Case Number:

IPR2019-00207

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Amneal Pharmaceuticals LLC

Patent Owner:

Almirall, LLC

Tech Center:

1600

1. Filed: November 06, 2018 00:00

   Coverage

   1. June 01, 2020

      Generics' 2nd Challenge To Acne Drug IP Succeeds At PTAB

      Handing a win to Amneal Pharmaceuticals and Mylan in a battle with Almirall LLC over a patent covering its acne drug Aczone, the Patent Trial and Appeal Board said the generics makers were able to persuasively show that all the challenged claims were invalid.

   2 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login